Lycia Therapeutics Shares Soar in Nasdaq Debut

12:27 PM EDT, 10/23/2026 (MT Newswires) -- Lycia Therapeutics (LYCA) shares were up 33% to $24 around midday in their Nasdaq Global Select Market debut on Friday. The company priced its initial public offerings of 17.6 million common shares at $18 apiece, and granted underwriters a 30-day option purchase up to an additional 2.6 million shares, according to a Thursday statement. The offering is expected to close on Monday, Lycia Therapeutics said. Price: 24.00, Change: +6.00, Percent Change: +33.33